Job lock, surging prescription drug costs, No Surprises Act update, and more from STAT's Health Care Inc.
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | STAT+: Bracing for another Fauci hearing | 0 | 10 | 28-07-2026 |
| 2 | STAT+: Ban prior auth? And hospitals cut jobs | 0 | 8.62 | 10-08-2026 |
| 3 | STAT+: Pharmalittle: We’re reading about a U.S. peptide panel’s votes, Amgen scuffling with the FDA, and more | 0 | 7.35 | 27-07-2026 |
| 4 | STAT+: Pharmalittle: We’re reading about a court win for Amgen, Novo seeking supplier discounts, and more | 0 | 5 | 02-07-2026 |
| 5 | STAT+: GSK lays out plans to cut costs, pursue more late-stage drug trials | 0 | 13.41 | 28-07-2026 |
| 6 | STAT+: An investigation into Commure, and Medicare’s new-tech incentives for AI devices | 0 | 9.08 | 13-08-2026 |
| 7 | STAT+: Roche drug sets new standard for KRAS-driven lung cancer | 5 | 7 | 02-07-2026 |
| 8 | STAT+: Medicare takes another swing at 340B cuts to hospitals | 0 | 5 | 02-07-2026 |
| 9 | STAT+: Three questions with Whoop’s new CMO | 0 | 6.5 | 28-07-2026 |
| 10 | STAT+: Pharmalittle: We’re reading about FDA views on a Duchenne drug, GSK cost savings, and more | 0 | 10.35 | 28-07-2026 |